F.D.A.’s Approval of a Drug for Autism Upends Review Process​

F.D.A.’s Approval of a Drug for Autism Upends Review Process​

F.D.A.’s Approval of a Drug for Autism Upends Review Process​

 The agency expanded use of an old drug as a treatment for some people with autism. The endorsement sent some customers scrambling to buy over-the-counter supplements with the same ingredients.  

Creator: The New York Times (NYTHealth)

Related Posts

Blue Planet Survival and the Future of Ocean Life
Blue Planet Survival
Planetary Resource Limits and the Cost of Overshoot
Planetary Resource Limits
Major One Health Conferences to Attend in July 2026
One Health Conferences July 2026

Most Recent

Spheres of Focus

Infectious Diseases

Climate & Disasters

Food &
Water

Natural
Resources

Built
Environments

Technology & Data

Featured Posts